Tag: psychotherapy research

“Making a Silk Purse Out of a Sow’s Ear”: Erick Turner...

5
Ayurdhi Dhar interviews Erick Turner about publication bias in antidepressant trials, compromised psychotherapeutic research, and a culture of journal worship.

Prominent Researcher and Psychotherapist Questions “Evidence-Based Therapy”

52
Dr. Johnathan Shedler recently published a paper critiquing how the term “evidence-based” is being used in the field of psychotherapy.

Researchers Advocate for More Robust Informed Consent in Psychotherapy

8
Paper outlines recommendations for more thorough informed consent process in psychotherapy, which authors proclaim is an “ethical imperative."

Researchers Question “Gold Standard” Status of Cognitive Behavioral Therapy

28
Researchers argue for plurality and diversity among psychotherapy approaches and question the perceived superiority of Cognitive Behavioral Therapy (CBT).

Researchers Push for Transparency of Mental Health Outcome Data

5
A new analysis of UK mental health data suggests the way organizations deliver mental health services can alter patient outcomes.

Have we Overestimated the Effectiveness of Psychotherapy?

3
From The British Psychological Society: A recent meta-analysis has raised concerns about the validity of previous studies on the effectiveness of psychotherapy, calling their methodology and...

Conflicts of Interest Found in Psychotherapy Research

1
Research highlights the need for conflict of interest transparency and management in systemic reviews of psychological therapies.

Therapy Effective and Efficient Long-Term For Depression

7
There is robust evidence for the long-term effectiveness of psychotherapy, and it also provides good value-for-money, according to a large randomized control trial published open-access this month in The Lancet. The researchers recommend that clinicians refer all patients with treatment-resistant depression to therapy.

NIMH Funding Changes Threaten Psychotherapy Research

8
The National Institute of Mental Health (NIMH) is increasingly shifting its research emphasis toward attempting to uncover biomarkers for “mental diseases,” which may have dramatic consequences for research and training in clinical psychology. In an article to be published in next month’s Professional Psychology: Research and Practice, Marvin Goldfried outlines how the shift in funding priorities for psychological research is tied to the needs of pharmaceutical companies and the biological model in psychiatry.